CNTGF — Crown LiquidationCo NV in liquidatie Share News
0.000.00%
Last trade - 00:00TechnologySpeculativeMicro Cap
- $3.48m
- $74.53m
- €48.54m
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice
Brief: Centogene Extends Strategic Partnership With Takeda To Continue Providing Access To Genetic Testing For Patients With Lysosomal Storage Disorders
Brief: Centogene Collaborates On Research Published In Science Showing Immunopathological Landscape Of Human Pre-TCRΑ Deficiency
Brief: Centogene Explores Strategic Alternatives
Brief: Centogene And The Michael J. Fox Foundation Announce Research Project To Validate Genetic Risk Factors Of Parkinson’s Disease Using Multiomics
Brief: Centogene Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
Brief: Centogene Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value Of Publicly Held Shares Deficiency
Brief: Centogene Regains Compliance With Nasdaq Listing Requirements
Brief: Centogene And Lifera Enter Strategic Collaboration
Brief: Centogene Receives Nasdaq Notification On Minimum Market Value Of Publicly Held Shares Deficiency
Brief: Centogene Reports Full Year 2022 Financial Results
Brief: Centogene Receives Nasdaq Non-Compliance Notice
Brief: Centogene Extends Strategic Partnership With Takeda
Centogene NV rises on extended genetic testing pact with Takeda
Brief: Centogene NV Says Does Not Hold Any Cash Deposits Or Securities At SVB, Signature Bank, First Republic Bank
Brief: Centogene Appoints Ian Rentsch As Chief Commercial Officer And General Manager